Creatine Monohydrate Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: muscle phosphocreatine and exercise performance

Amino Acids & Nutrients compound PowderCapsule verified

Also known as: Creatine

Quick Facts

Reference Sizes
250 g, 500 g, 1 kg, 200 capsules
Storage
Store dry at room temperature in a tightly closed container; avoid prolonged storage after mixing in acidic liquid
Solubility
Limited water solubility at room temperature; warm water improves dissolution but does not change total ingested dose

Catalog Description

Creatine monohydrate is the most extensively studied creatine form. A loading phase raises muscle stores quickly but is not required; lower daily intake reaches similar saturation more gradually. It is a nutrient supplement rather than a peptide or research drug.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
A single plasma half-life is less relevant than muscle-store saturation and turnover; stores rise rapidly with loading or over approximately four weeks with 3 g/day
Onset
Muscle stores can approach saturation after 5-7 days of loading or about 3-4 weeks without loading
Administration Routes (Research)
Oral

Reported Research Effects

Reported Research Side Effects

Data source: NIH guidance, ISSN position stand, and current retail packaging

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Route-Specific Research Protocols

Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.

Label / guideline Human study Community only Preclinical only Not established
Oral Human study only

5 g four times daily

Frequency / timing
Four divided doses
Duration / setting
5-7 days
Technique
Oral
Evidence
Human study protocol

Context: ISSN position stand PMCID PMC5469049

Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.

Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.

Oral Human study only

3-5 g once daily

Frequency / timing
Daily
Duration / setting
Ongoing maintenance
Technique
Oral
Evidence
Human study protocol

Context: NIH ODS and ISSN position stand

Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.

Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.

Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.

Research Notes

Current powders are commonly sold in 250 g 500 g and 1 kg containers; capsule products also exist. Community practice aligns with 3-5 g/day but is not needed to establish the evidence-based protocol.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

ISSN position stand on creatine supplementation — PubMed Central (NIH)
https://pmc.ncbi.nlm.nih.gov/articles/PMC5469049/
Dietary Supplements for Exercise and Athletic Performance — NIH Office of Dietary Supplements
https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top